Plas-Free Israeli Company

Plas-Free has developed ClearPlasma, an extracorporeal device designed to effectively and specifically extract plasma proteins responsible for hyperfibrinolysis. The Plas-Free device enables physicians to improve transfused plasma and shift the hemostasis from hyperfibrinolysis to coagulation, subsequently preventing massive bleeding.